Copaxone in therapy of remittent disseminated sclerosis patients
Twenty three remittent disseminated sclerosis patients have been observed for two years to study the influence of copaxone on clinical manifestations and course of their disease in relation to the state of membrane- destabilizing processes in erythrocytes.
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Siberian State Medical University (Tomsk)
2008-09-01
|
Series: | Бюллетень сибирской медицины |
Subjects: | |
Online Access: | https://bulletin.ssmu.ru/jour/article/view/3503 |
_version_ | 1797873265476108288 |
---|---|
author | O. A. Kitcherova L. I. Reikhert S. M. Bychenko A. A. Sokolova |
author_facet | O. A. Kitcherova L. I. Reikhert S. M. Bychenko A. A. Sokolova |
author_sort | O. A. Kitcherova |
collection | DOAJ |
description | Twenty three remittent disseminated sclerosis patients have been observed for two years to study the influence of copaxone on clinical manifestations and course of their disease in relation to the state of membrane- destabilizing processes in erythrocytes. |
first_indexed | 2024-04-10T01:12:22Z |
format | Article |
id | doaj.art-cb2d7f32baff4a74bfb3fcfdbe53098f |
institution | Directory Open Access Journal |
issn | 1682-0363 1819-3684 |
language | English |
last_indexed | 2024-04-10T01:12:22Z |
publishDate | 2008-09-01 |
publisher | Siberian State Medical University (Tomsk) |
record_format | Article |
series | Бюллетень сибирской медицины |
spelling | doaj.art-cb2d7f32baff4a74bfb3fcfdbe53098f2023-03-13T09:58:08ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842008-09-017310411010.20538/1682-0363-2008-3-104-1102149Copaxone in therapy of remittent disseminated sclerosis patientsO. A. Kitcherova0L. I. Reikhert1S. M. Bychenko2A. A. Sokolova3Тюменская государственная медицинская академияТюменская государственная медицинская академияТюменская государственная медицинская академияТюменская государственная медицинская академияTwenty three remittent disseminated sclerosis patients have been observed for two years to study the influence of copaxone on clinical manifestations and course of their disease in relation to the state of membrane- destabilizing processes in erythrocytes.https://bulletin.ssmu.ru/jour/article/view/3503рассеянный склерозкопаксонперекисное окисление липидов |
spellingShingle | O. A. Kitcherova L. I. Reikhert S. M. Bychenko A. A. Sokolova Copaxone in therapy of remittent disseminated sclerosis patients Бюллетень сибирской медицины рассеянный склероз копаксон перекисное окисление липидов |
title | Copaxone in therapy of remittent disseminated sclerosis patients |
title_full | Copaxone in therapy of remittent disseminated sclerosis patients |
title_fullStr | Copaxone in therapy of remittent disseminated sclerosis patients |
title_full_unstemmed | Copaxone in therapy of remittent disseminated sclerosis patients |
title_short | Copaxone in therapy of remittent disseminated sclerosis patients |
title_sort | copaxone in therapy of remittent disseminated sclerosis patients |
topic | рассеянный склероз копаксон перекисное окисление липидов |
url | https://bulletin.ssmu.ru/jour/article/view/3503 |
work_keys_str_mv | AT oakitcherova copaxoneintherapyofremittentdisseminatedsclerosispatients AT lireikhert copaxoneintherapyofremittentdisseminatedsclerosispatients AT smbychenko copaxoneintherapyofremittentdisseminatedsclerosispatients AT aasokolova copaxoneintherapyofremittentdisseminatedsclerosispatients |